Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Short communication: Lack of immune response in rapid progressor morphine-dependent and SIV/SHIV-infected rhesus macaques is correlated with downregulation of TH1 cytokines.

Rivera-Amill V, Kumar R, Noel RJ Jr, Garcia Y, Rodriguez IV, Martinez M, Sariol CA, Kraiselburd E, Iszard M, Mukherji M, Kumar S, Giavedoni LD, Kumar A.

AIDS Res Hum Retroviruses. 2010 Aug;26(8):919-22. doi: 10.1089/aid.2010.0012.

3.

Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques.

Kumar R, Orsoni S, Norman L, Verma AS, Tirado G, Giavedoni LD, Staprans S, Miller GM, Buch SJ, Kumar A.

Virology. 2006 Oct 10;354(1):192-206. Epub 2006 Jul 28.

4.

Variable region 4 of SIV envelope correlates with rapid disease progression in morphine-exposed macaques infected with SIV/SHIV.

Rivera-Amill V, Noel RJ Jr, Orsini S, Tirado G, García JM, Buch S, Kumar A.

Virology. 2007 Feb 20;358(2):373-83. Epub 2006 Sep 28.

5.

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile.

Haigwood NL, Watson A, Sutton WF, McClure J, Lewis A, Ranchalis J, Travis B, Voss G, Letvin NL, Hu SL, Hirsch VM, Johnson PR.

Immunol Lett. 1996 Jun;51(1-2):107-14.

PMID:
8811353
6.

Interaction of SIV/SHIV infection and morphine on plasma oxidant/antioxidant balance in macaque.

Pérez-Casanova A, Husain K, Noel RJ Jr, Rivera-Amill V, Kumar A.

Mol Cell Biochem. 2008 Jan;308(1-2):169-75. Epub 2007 Oct 13.

PMID:
17934700
7.

Expression of IL-18 by SIV does not modify the outcome of the antiviral immune response.

Giavedoni LD, Velasquillo MC, Parodi LM, Hubbard GB, Hodara VL.

Virology. 2002 Nov 25;303(2):327-37.

8.

Evolution of SIV envelope in morphine-dependent rhesus macaques with rapid disease progression.

Tirado G, Kumar A.

AIDS Res Hum Retroviruses. 2006 Jan;22(1):114-9.

PMID:
16438654
9.

Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.

Kumar A, Mukherjee S, Shen J, Buch S, Li Z, Adany I, Liu Z, Zhuge W, Piatak M Jr, Lifson J, McClure H, Narayan O.

Virology. 2002 Sep 30;301(2):189-205.

10.

Innate differences between simian-human immunodeficiency virus (SHIV)(KU-2)-infected rhesus and pig-tailed macaques in development of neurological disease.

Buch SJ, Villinger F, Pinson D, Hou Y, Adany I, Li Z, Dalal R, Raghavan R, Kumar A, Narayan O.

Virology. 2002 Mar 30;295(1):54-62.

11.

Correlation between SIV Tat evolution and AIDS progression in cerebrospinal fluid of morphine-dependent and control macaques infected with SIV and SHIV.

Noel RJ Jr, Marrero-Otero Z, Kumar R, Chompre-González GS, Verma AS, Kumar A.

Virology. 2006 Jun 5;349(2):440-52. Epub 2006 Apr 27.

12.

Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques.

Marthas ML, van Rompay KK, Otsyula M, Miller CJ, Canfield DR, Pedersen NC, McChesney MB.

J Virol. 1995 Jul;69(7):4198-205.

13.

Analysis of the V1V2 region of the SIV envelope in the brains of morphine-dependent and control SIV/SHIV-infected macaques.

Rivera-Amill V, Noel RJ Jr, Román IR, Flores YG, Buch S, Kumar A.

AIDS Res Hum Retroviruses. 2009 May;25(5):531-4. doi: 10.1089/aid.2008.0279.

14.

Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.

Miller CJ, McChesney MB, Lü X, Dailey PJ, Chutkowski C, Lu D, Brosio P, Roberts B, Lu Y.

J Virol. 1997 Mar;71(3):1911-21.

16.

Immunological and virological studies of natural SIV infection of disease-resistant nonhuman primates.

Villinger F, Folks TM, Lauro S, Powell JD, Sundstrom JB, Mayne A, Ansari AA.

Immunol Lett. 1996 Jun;51(1-2):59-68.

PMID:
8811346
17.

Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques.

Hirsch VM, Santra S, Goldstein S, Plishka R, Buckler-White A, Seth A, Ourmanov I, Brown CR, Engle R, Montefiori D, Glowczwskie J, Kunstman K, Wolinsky S, Letvin NL.

J Virol. 2004 Jan;78(1):275-84.

18.

Infected macaques that controlled replication of SIVmac or nonpathogenic SHIV developed sterilizing resistance against pathogenic SHIV(KU-1).

Stephens EB, Joag SV, Atkinson B, Sahni M, Li Z, Foresman L, Adany I, Narayan O.

Virology. 1997 Aug 4;234(2):328-39.

19.

Identification and molecular characterization of SIV Vpr R50G mutation associated with long term survival in SIV-infected morphine dependent and control macaques.

Rivera I, García Y, Gangwani MR, Noel RJ Jr, Maldonado L, Kumar A, Rivera-Amill V.

Virology. 2013 Nov;446(1-2):144-51. doi: 10.1016/j.virol.2013.07.027. Epub 2013 Aug 28.

20.

Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus.

Kumar R, Torres C, Yamamura Y, Rodriguez I, Martinez M, Staprans S, Donahoe RM, Kraiselburd E, Stephens EB, Kumar A.

J Virol. 2004 Oct;78(20):11425-8.

Items per page

Supplemental Content

Write to the Help Desk